Skip to Main content

Social networks

    Number of documents

    26

    Nicolas Azzopardi


    Journal articles25 documents

    • Amina Bensalem, Denis Mulleman, Gilles Thibault, Nicolas Azzopardi, Philippe Goupille, et al.. CD4+ count‐dependent concentration‐effect relationship of rituximab in rheumatoid arthritis. British Journal of Clinical Pharmacology, Wiley, 2019, ⟨10.1111/bcp.14102⟩. ⟨hal-02376303⟩
    • Thomas Secher, Emilie Dalonneau, Marion Ferreira, Christelle Parent, Nicolas Azzopardi, et al.. In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration. Journal of Controlled Release, Elsevier, 2019, 303, pp.24-33. ⟨10.1016/j.jconrel.2019.04.005⟩. ⟨hal-02179896⟩
    • Amina Bensalem, Denis Mulleman, Gilles Paintaud, Nicolas Azzopardi, Valerie Gouilleux-Gruart, et al.. Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited. Clinical Pharmacokinetics, Springer Verlag, 2019, ⟨10.1007/s40262-019-00826-5⟩. ⟨hal-02316414⟩
    • David Ternant, Nicolas Azzopardi, William Raoul, Theodora Bejan-Angoulvant, Gilles Paintaud. Influence of Antigen Mass on the Pharmacokinetics of Therapeutic Antibodies in Humans. Clinical Pharmacokinetics, Springer Verlag, In press, ⟨10.1007/s40262-018-0680-3⟩. ⟨hal-01821717⟩
    • Christophe Arnoult, Guillaume Brachet, Diana Cadena Castaneda, Nicolas Azzopardi, Christophe Passot, et al.. Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti–TNF-α Antibodies after a Single Injection in Mice. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2017, 199 (2), pp.418 - 424. ⟨10.4049/jimmunol.1601246⟩. ⟨hal-01769804⟩
    • Christophe Arnoult, Guillaume Brachet, Diana Castaneda, Nicolas Azzopardi, Christophe Passot, et al.. Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti–TNF-α Antibodies after a Single Injection in Mice. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2017, 199 (2), pp.418-424. ⟨10.4049/jimmunol.1601246⟩. ⟨hal-02019721⟩
    • Yoann Pointreau, Nicolas Azzopardi, David Ternant, Gilles Calais, Gilles Paintaud. Cetuximab pharmacokinetics influences overall survival in head and neck cancer patients. Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2017, pp.567-72. ⟨10.1097/FTD.0000000000000321⟩. ⟨hal-01769813⟩
    • Mira Tout, Anne-Laure Gagez, Stéphane Lepretre, Valérie Gouilleux-Gruart, Nicolas Azzopardi, et al.. Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group. Clinical Pharmacokinetics, Springer Verlag, 2017, 56 (6), pp.635 - 647. ⟨10.1007/s40262-016-0470-8⟩. ⟨hal-01769807⟩
    • Morgane Caulet, Thierry Lecomte, Olivier Bouché, Jérôme Rollin, Valérie Gouilleux-Gruart, et al.. Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer Patients. Clinical Pharmacokinetics, Springer Verlag, 2016, 55 (11), pp.1381 - 1394. ⟨10.1007/s40262-016-0406-3⟩. ⟨hal-01769811⟩
    • Jérôme Rollin, Audrey Payancé, Valérie Gouilleux-Gruart, Michelle Boisdron-Celle, Nicolas Azzopardi, et al.. Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab. Pharmacogenomics, Future Medicine, 2015, 16 (18), pp.2035-2043. ⟨10.2217/pgs.15.139⟩. ⟨hal-02381189⟩
    • David Ternant, Konstantinos Karmiris, Séverine Vermeire, Celine Desvignes, Nicolas Azzopardi, et al.. Pharmacokinetics of adalimumab in Crohn’s disease. European Journal of Clinical Pharmacology, Springer Verlag, 2015, 71 (9), pp.1155 - 1157. ⟨10.1007/s00228-015-1892-1⟩. ⟨hal-01769822⟩
    • Nicolas Azzopardi, Sophie Dupuis-Girod, David Ternant, Anne-Emmanuelle Fargeton, Isabelle Ginon, et al.. Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasia. mAbs, Taylor & Francis, 2015, 7 (3), pp.630 - 637. ⟨10.1080/19420862.2015.1022693⟩. ⟨hal-01769884⟩
    • Virginie Herve, Nathalie Rabbe, Laurent Guilleminault, Flora Paul, Laurène Schlick, et al.. VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations. mAbs, Taylor & Francis, 2014, 6 (6), pp.1638 - 1648. ⟨10.4161/mabs.34454⟩. ⟨hal-01769888⟩
    • Christophe Passot, Nicolas Azzopardi, Sylvaine Renault, Nadine Baroukh, Christophe Arnoult, et al.. Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies. mAbs, Taylor & Francis, 2014, 5 (4), pp.614 - 619. ⟨10.4161/mabs.24815⟩. ⟨hal-01769897⟩
    • L. Guilleminault, N. Azzopardi, C. Arnoult, J. Sobilo, V. Herve, et al.. Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system. Journal of Controlled Release, Elsevier, 2014, 196, pp.344-354. ⟨10.1016/j.jconrel.2014.10.003⟩. ⟨hal-02376374⟩
    • Nicolas Azzopardi, Maud François, Emeline Laurent, Gilles Paintaud, Beatrice Birmelé. Influence of plasma exchange on rituximab pharmacokinetics. British Journal of Clinical Pharmacology, Wiley, 2013, 76 (3), pp.486 - 488. ⟨10.1111/bcp.12167⟩. ⟨hal-01769901⟩
    • Agnes Maillet, Laurent Guilleminault, Etienne Lemarié, Stephanie Lerondel, Nicolas Azzopardi, et al.. The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors. Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2011, 28 (9), pp.2147 - 2156. ⟨10.1007/s11095-011-0442-5⟩. ⟨hal-01769936⟩
    • Nicolas Azzopardi, Therry Lecomte, David Ternant, Michele Boisdron-Celle, Friedrich Piller, et al.. Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients. Fundamental and Clinical Pharmacology, Wiley, 2011, 25, pp.34-34. ⟨hal-00616314⟩
    • Nicolas Azzopardi, Thierry Lecomte, David Ternant, Michelle Boisdron-Celle, Friedrich Piller, et al.. Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients. Clinical Cancer Research, American Association for Cancer Research, 2011, 17 (19), pp.6329 - 6337. ⟨10.1158/1078-0432.CCR-11-1081⟩. ⟨hal-01769933⟩
    • D Chu Miow Lin, D. Mulleman, N. Azzopardi, G Griffoul-Espitalier, P Valat, et al.. Trough infliximab concentration may predict long-term maintenance of infliximab in ankylosing spondylitis. Scandinavian Journal of Rheumatology, Taylor & Francis, 2010, 39 (1), pp.97 - 98. ⟨10.3109/03009740903177745⟩. ⟨hal-01769938⟩
    • D. Chu Miow Lin, D. Mulleman, N. Azzopardi, I. Griffoul-Espitalier, J.-P. Valat, et al.. Trough infliximab concentration may predict long-term maintenance of infliximab in ankylosing spondylitis. Scandinavian Journal of Rheumatology, Taylor & Francis, 2010, 39 (1), pp.97-98. ⟨hal-00616813⟩
    • Nicolas Ceze, David Ternant, Friedrich Piller, Danielle Degenne, Nicolas Azzopardi, et al.. An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Cetuximab. Ther. Drug Monit., 2009, 31 (5), pp.597-601. ⟨hal-00616405⟩
    • Agnes Maillet, Laurent Guilleminault, Nicolas Azzopardi, Jerome Montharu, Laurent Vecellio, et al.. Aerosoltherapy for lung tumors using the monoclonal antibody cetuximab. Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2009, 4 (9), pp.S600-S600. ⟨hal-00616858⟩
    • Nicolas Ceze, David Ternant, Friedrich Piller, Danielle Degenne, Nicolas Azzopardi, et al.. An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Cetuximab. Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2009, 31 (5), pp.597-601. ⟨hal-00521871⟩
    • Juliette Thariat, Nicolas Azzopardi, Frederic Peyrade, Vincent Launay-Vacher, Jose Santini, et al.. Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis. Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (25), pp.4223-4225. ⟨hal-00616934⟩

    Poster communications1 document

    • A Bensalem, D Ternant, N. Azzopardi, G. Paintaud, V Gouilleux-Gruart, et al.. Relationship between rituximab concentration and autoantibody levels in anti-neutrophil cytoplasmic antibody associated vasculitis. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02149477⟩